17 July 2022
: Case report 
A 46-Year-Old Thai Woman with Secondary Acquired Pure Red Cell Aplasia Due to Treatment with Recombinant Erythropoietin While on Dialysis for End-Stage Renal Disease Who Recovered Following ABO-Incompatible Kidney Transplantation
Challenging differential diagnosis, Unusual setting of medical care, Rare disease
Rungthiwa Kitpermkiat1BDEF, Sansanee Thotsiri1BD, Nuttaporn Arpornsujaritkun2B, Premsant Sangkum3B, Pichika Chantrathammachart4BD, Pimpun Kitpoka5BD, Duangtawan Thammanichanond5BD, Tanist Virankabutra6B, Surasak Kantachuvesiri1BDE*DOI: 10.12659/AJCR.935451
Am J Case Rep 2022; 23:e935451
Figure 2. The time course of anemia, blood transfusions, and ESA exposure. The absolute reticulocyte counts on day −20 and day −10 after triple-immunosuppressive drugs were 40 600/microL and 34 000/microL, respectively. The left Y-axis represents hemoglobin level, the right Y-axis represents unit per month of Retracrit®, the orange arrows indicate administration of 75 mcg of CERA, the green arrows indicate blood transfusion. PRC – pack red cell; Hb – hemoglobin.